Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/27/2005 | US6979764 Transgenic seeds, plants, tissue culture, protoplasts; crossbreeding, backcrossing; male sterility, resistant to herbicide, insect and disease; modifying metabolism of fatty acid, phytic acid or carbohydrate |
12/27/2005 | US6979763 Hybrid maize plant & seed 38G60 |
12/27/2005 | US6979761 Soybean cultivar S030159 |
12/27/2005 | US6979759 Soybean variety 93B09 |
12/27/2005 | US6979733 Comprises nucleotide sequences coding biocatalyst polypeptide for hydrolysis of epoxides and arene oxides into diols such as glycidol and atenolol; antiinflammatory/hypotensive agents |
12/27/2005 | US6979557 Comprise olignucleotide sequences associated with translation initiation for analyzing the function of polypeptide |
12/27/2005 | US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins |
12/27/2005 | US6979443 Chemokine α-6 |
12/27/2005 | US6979308 Bioreactor design and process for engineering tissue from cells |
12/27/2005 | CA2295594C A method of reducing signal coupling in a connector, a connector and a cable including such a connector |
12/22/2005 | WO2005121342A1 Recombinant enterotoxin c and vaccine with the use of the same |
12/22/2005 | WO2005121340A1 Novel galectin 8 modification protein and use thereof |
12/22/2005 | WO2005121338A1 Anti-perp antibody |
12/22/2005 | WO2005121335A1 Episomal fusion gene |
12/22/2005 | WO2005121325A1 Heart and skeletal muscle inflammation (hsmi) virus |
12/22/2005 | WO2005121324A1 Es cell mutation method and system |
12/22/2005 | WO2005121323A2 Methods for ex vivo propagation of somatic hair follicle stem cells |
12/22/2005 | WO2005121322A1 Enzymatic modification of cell-surface h antigen by glycosyltransferases |
12/22/2005 | WO2005121321A2 Compositions comprising female germline stem cells and methods of use thereof |
12/22/2005 | WO2005121320A1 Autonomouos replication promoter for stem cells |
12/22/2005 | WO2005121319A1 Methods for production of mesodermal lineage cells |
12/22/2005 | WO2005121318A2 Neural stem cells |
12/22/2005 | WO2005121317A2 Method for obtaining mesenchymal stem cells |
12/22/2005 | WO2005121316A1 Tissue material and muscle derived matrix |
12/22/2005 | WO2005121176A1 Angiogenesis-inhibiting chimeric protein and the use |
12/22/2005 | WO2005120701A1 Stable composite material comprising supported porous gels |
12/22/2005 | WO2005120576A2 Composition and method for improving pancreatic islet cell survival |
12/22/2005 | WO2005120575A1 Method of regenerating follicles by inhibiting gene capable of inhibting follicle formation or activating gene capable of inducing follicle formation |
12/22/2005 | WO2005096706A3 Antibody to 5'-deoxy-5'-methylthioadenosine and uses thereof |
12/22/2005 | WO2005078108A3 Stress resistant plants |
12/22/2005 | WO2005069969A3 Mutant sodium channel nav1.7 and methods related thereto |
12/22/2005 | WO2005067477A3 Anti-human lymphotoxin alpha antibodies, compositions, methods and uses |
12/22/2005 | WO2005013912A3 Anti-fcrn antibodies for treatment of auto/allo immune conditions |
12/22/2005 | WO2004082370A3 Cardiac-preferred genetic alteration of transgenic rabbits |
12/22/2005 | WO2004070004A3 Rat receptor tyrosine kinase, kdr |
12/22/2005 | WO2004048595A3 Vascular-preferred promoters |
12/22/2005 | WO2003057856A3 Dominant negative proteins and methods thereof |
12/22/2005 | WO2002083874A3 Endothelial cell expression patterns |
12/22/2005 | US20050283862 Inbred corn line PHB1V |
12/22/2005 | US20050283858 Brassica AHAS genes and gene alleles that provide resistance to imidazolinone herbicides |
12/22/2005 | US20050283854 Recombinant vectors for use in position-independent transgene expression within chromatin |
12/22/2005 | US20050283853 Methods and genetic compositions to limit outcrossing and undesired gene flow in crop plants |
12/22/2005 | US20050283852 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment |
12/22/2005 | US20050283851 Novel genes encoding proteins involved in proanthocyanidin synthesis |
12/22/2005 | US20050283848 Expression of eukaryotic peptides in plant plastids |
12/22/2005 | US20050283845 Method for producing non-human mammal having RNAi phenotype |
12/22/2005 | US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
12/22/2005 | US20050282764 Method of identifying nucleic acid compositions for muting expression of a gene |
12/22/2005 | US20050282740 Methods and compositions for regulating protein-protein interactions |
12/22/2005 | US20050282282 Methods of use of viral vectors to deliver antigen to dendritic cells |
12/22/2005 | US20050282277 Methods of increasing platelet and hematopoietic stem cell production |
12/22/2005 | US20050282276 Cell fractions containing cells capable of differentiating into neural cells |
12/22/2005 | US20050282275 Adipose-derived stem cells and lattices |
12/22/2005 | US20050282274 Osteoblast precursors from human embryonic stem cells |
12/22/2005 | US20050282273 Medium and methods for culturing of avian primordial germ cells |
12/22/2005 | US20050282272 inducing a reduced lymphocyte proliferative response to a Major Histocomatibilty Complex (MHC) type presented on an human embryonic stem (hES) cell in a subject; induces a state of inflammatory quiescence or immune unresponsiveness, which in turn enhances engraftment of the stem cells |
12/22/2005 | US20050282271 Cell; extracellular, plasma membrane associated cyto-compatible glycoconjugate, a monosaccharide; cancer diagnosis |
12/22/2005 | US20050282256 Adipocyte complement related protein zacrp13 |
12/22/2005 | US20050282255 Cell growth differentiation factor (MP52) for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents |
12/22/2005 | US20050282245 Use of a composition which regulates oxidation/reduction reactions intracellularly and/or extracellularly in a staining or sorting process |
12/22/2005 | US20050282230 Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method |
12/22/2005 | US20050282223 TR3-specific binding agents and methods for their use |
12/22/2005 | US20050282216 Purified polypeptides having IL-13 receptor activity |
12/22/2005 | US20050282201 Cell-based detection and differentiation of lung cancer |
12/22/2005 | US20050282184 Methods and reagents for molecular cloning |
12/22/2005 | US20050282152 Drug testing with bio-artificial organ slices including for example those derived from liver |
12/22/2005 | US20050282150 Identifying an inhibitor of cyclin E2 polypeptide/cyclic-dependent kinase-2 complex formation by allowing a cyclin E2 polypeptide having a specific sequence and cdk2 to spontaneously associate to form a cyclin E2 polypeptide/cdk2 complex; adding test compound; and assaying for a decrease in complex |
12/22/2005 | US20050282148 permit the assessment of agents without administration to subjects; using the artificial immune system of the invention for evaluating the potential reaction of a diseased animal to an agent |
12/22/2005 | US20050282147 Methods for assaying gene imprinting and methylated CpG islands |
12/22/2005 | US20050281831 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors |
12/22/2005 | US20050281815 CD40 splice variants and their uses |
12/22/2005 | US20050281812 Antibodies to insulin-like growth factor I receptor |
12/22/2005 | US20050281793 T cell activation |
12/22/2005 | US20050281791 Method for inducing cardiac myocytes in embryonic stem (ES) cells by induction with precardiac endoderm and mesoderm |
12/22/2005 | US20050281790 Mesenchymal precursor cell |
12/22/2005 | US20050281789 Transcutaneous and/or transdermal transport of materials |
12/22/2005 | US20050281788 Compositions comprising muscle progenitor cells and uses thereof |
12/22/2005 | US20050279730 Method for manufacturing cell culture substrate |
12/22/2005 | CA2609260A1 Rna-containing microvesicles and methods therefor |
12/22/2005 | CA2573430A1 Anti-perp antibody |
12/22/2005 | CA2570050A1 Heart and skeletal muscle inflammation (hsmi) virus |
12/22/2005 | CA2569978A1 Neural stem cells |
12/22/2005 | CA2566851A1 Compositions comprising female germline stem cells and methods of use thereof |
12/22/2005 | CA2566647A1 Inhibition of macrophage-stimulating protein receptor (ron) |
12/22/2005 | CA2564784A1 Episomal fusion gene |
12/22/2005 | CA2564413A1 Stable composite material comprising supported porous gels |
12/22/2005 | CA2507844A1 Brassica ahas genes and gene alleles that provide resistance to imidazolinone herbicides |
12/22/2005 | CA2469139A1 Potato regeneration system and use thereof |
12/22/2005 | CA2469098A1 Pathogen inducible plant promoter and use thereof |
12/21/2005 | EP1607402A1 Method for the diagnosis of tumour |
12/21/2005 | EP1607108A1 Blood vessel-specific organogenesis from embryonic stem cells on three-dimensional matrigel layer |
12/21/2005 | EP1606396A2 Methods of promoting the differentiation of stem cells |
12/21/2005 | EP1606395A2 Accelerated culture system for intestinal epithelial cell monolayers |
12/21/2005 | EP1606388A2 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
12/21/2005 | EP1606065A2 Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon |
12/21/2005 | EP1605982A2 Compositions for neuronal tissue regeneration |
12/21/2005 | EP1605965A1 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome |
12/21/2005 | EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
12/21/2005 | EP1534754A4 Bi-specific antigen-binding compositions and related methods |
12/21/2005 | EP1509087A4 Treatment for diabetes |